Clinical Trials Browser

Has results × farletuzumab × Gynecologic × Clear all

NCT00849667 2022-12-30

Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse

Phase 3 Terminated

1,100 enrolled 30 charts

Ovarian Neoplasms

NCT00738699 2017-03-30

FAR-122

Phase 2 Terminated

415 enrolled 11 charts

Ovarian Neoplasms

NCT00318370 2015-09-09

Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy

Phase 2 Completed

58 enrolled 12 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms